102 related articles for article (PubMed ID: 2681551)
1. Stage-shift cancer screening model.
Connor RJ; Chu KC; Smart CR
J Clin Epidemiol; 1989; 42(11):1083-95. PubMed ID: 2681551
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the temporal patterns of benefits in the Health Insurance Plan of Greater New York trial by stage and age.
Chu KC; Connor RJ
Am J Epidemiol; 1991 May; 133(10):1039-49. PubMed ID: 2035504
[TBL] [Abstract][Full Text] [Related]
3. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
[TBL] [Abstract][Full Text] [Related]
4. The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods.
Mandelblatt J; Schechter CB; Lawrence W; Yi B; Cullen J
J Natl Cancer Inst Monogr; 2006; (36):47-55. PubMed ID: 17032894
[TBL] [Abstract][Full Text] [Related]
5. [Breast cancer--incidence, mortality and stage shifting in Norway].
Zahl PH
Tidsskr Nor Laegeforen; 1997 Oct; 117(26):3765-7. PubMed ID: 9417678
[TBL] [Abstract][Full Text] [Related]
6. Impact of a cancer screening program on breast cancer stage at diagnosis in a medically underserved urban community.
Oluwole SF; Ali AO; Adu A; Blane BP; Barlow B; Oropeza R; Freeman HP
J Am Coll Surg; 2003 Feb; 196(2):180-8. PubMed ID: 12595043
[TBL] [Abstract][Full Text] [Related]
7. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
8. Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening.
Autier P; Héry C; Haukka J; Boniol M; Byrnes G
J Clin Oncol; 2009 Dec; 27(35):5919-23. PubMed ID: 19884547
[TBL] [Abstract][Full Text] [Related]
9. Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial.
Chu KC; Smart CR; Tarone RE
J Natl Cancer Inst; 1988 Sep; 80(14):1125-32. PubMed ID: 3411625
[TBL] [Abstract][Full Text] [Related]
10. A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer.
Kommalapati A; Tella SH; Goyal G; Ganti AK; Krishnamurthy J; Tandra PK
Breast Cancer Res Treat; 2018 Aug; 170(3):677-685. PubMed ID: 29721715
[TBL] [Abstract][Full Text] [Related]
11. Effect of screening mammography on breast cancer survival in comparison to other detection methods: a retrospective cohort study.
Kawai M; Kuriyama S; Suzuki A; Nishino Y; Ishida T; Ohnuki K; Amari M; Tsuji I; Ohuchi N
Cancer Sci; 2009 Aug; 100(8):1479-84. PubMed ID: 19493274
[TBL] [Abstract][Full Text] [Related]
12. Predicting the stage shift as a result of breast cancer screening in low- and middle-income countries: a proof of concept.
Zelle SG; Baltussen R; Otten JD; Heijnsdijk EA; van Schoor G; Broeders MJ
J Med Screen; 2015 Mar; 22(1):8-19. PubMed ID: 25416699
[TBL] [Abstract][Full Text] [Related]
13. Estimated Mortality of Breast Cancer Patients Based on Stage at Diagnosis and National Screening Guideline Categorization.
Patel SB
J Am Coll Radiol; 2018 Sep; 15(9):1206-1213. PubMed ID: 29793836
[TBL] [Abstract][Full Text] [Related]
14. Benefits of screening for breast cancer: application of a probabilistic model to a breast cancer detection project.
Dubin N
J Chronic Dis; 1979; 32(1-2):145-51. PubMed ID: 447774
[No Abstract] [Full Text] [Related]
15. Breast cancer biology and ethnic disparities in breast cancer mortality in new zealand: a cohort study.
Seneviratne S; Lawrenson R; Scott N; Kim B; Shirley R; Campbell I
PLoS One; 2015; 10(4):e0123523. PubMed ID: 25849101
[TBL] [Abstract][Full Text] [Related]
16. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
[TBL] [Abstract][Full Text] [Related]
17. Assessment of care by breast cancer patients participating or not participating in a randomized controlled trial: a report with the Patients' Committee for Clinical Trials of the Ligue Nationale Contre le Cancer.
Julian-Reynier C; Genève J; Dalenc F; Genre D; Monnier A; Kerbrat P; Largillier R; Serin D; Rios M; Roché H; Jimenez M; Tarpin C; Maraninchi D;
J Clin Oncol; 2007 Jul; 25(21):3038-44. PubMed ID: 17536083
[TBL] [Abstract][Full Text] [Related]
18. The University of Rochester model of breast cancer detection and survival.
Hanin LG; Miller A; Zorin AV; Yakovlev AY
J Natl Cancer Inst Monogr; 2006; (36):66-78. PubMed ID: 17032896
[TBL] [Abstract][Full Text] [Related]
19. Is the incidence of advanced-stage breast cancer affected by whether women attend a steady-state screening program?
de Munck L; Fracheboud J; de Bock GH; den Heeten GJ; Siesling S; Broeders MJM
Int J Cancer; 2018 Aug; 143(4):842-850. PubMed ID: 29574967
[TBL] [Abstract][Full Text] [Related]
20. [Alterations of stage distribution for breast cancer since the implementation of national screening program in the Netherlands during 1989-1995].
van Dijck JA; Hendriks JH; Holland R; Schouten LJ; Verbeek AL
Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1119-24. PubMed ID: 10876707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
